Organogenesis Holdings, Inc. (ORGO)
4.23
+0.23
(+5.75%)
USD |
NASDAQ |
Feb 02, 16:00
4.22
-0.01
(-0.24%)
After-Hours: 19:59
Organogenesis Holdings Market Cap : 536.84M for Feb. 2, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Integra LifeSciences Holdings Corp. | 869.28M |
| Celularity, Inc. | 35.69M |
| NovaBay Pharmaceuticals, Inc. | 215.76M |
| Palatin Technologies, Inc. | 16.04M |
| Theriva Biologics, Inc. | 6.006M |
Market Cap Related Metrics
| PS Ratio | 1.173 |
| PEG Ratio | -0.5905 |
| Price to Book Value | 2.104 |
| Price | 4.23 |
| Earnings Yield | -2.32% |
| PEGY Ratio | -0.5905 |
| Operating PE Ratio | 302.40 |